The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study

Philip J Johnson, Sofi Dhanaraj, Sarah Berhane, Laura Bonnett, Yuk Ting Ma

Research output: Contribution to journalArticlepeer-review

103 Downloads (Pure)

Abstract

BACKGROUND: The neutrophil-lymphocyte ratio (NLR), a presumed measure of the balance between neutrophil-associated pro-tumour inflammation and lymphocyte-dependent antitumour immune function, has been suggested as a prognostic factor for several cancers, including hepatocellular carcinoma (HCC).

METHODS: In this study, a prospectively accrued cohort of 781 patients (493 HCC and 288 chronic liver disease (CLD) without HCC) were followed-up for more than 6 years. NLR levels between HCC and CLD patients were compared, and the effect of baseline NLR on overall survival amongst HCC patients was assessed via multivariable Cox regression analysis.

RESULTS: On entry into the study ('baseline'), there was no clinically significant difference in the NLR values between CLD and HCC patients. Amongst HCC patients, NLR levels closest to last visit/death were significantly higher compared to baseline. Multivariable Cox regression analysis showed that NLR was an independent prognostic factor, even after adjustment for the HCC stage.

CONCLUSION: NLR is a significant independent factor influencing survival in HCC patients, hence offering an additional dimension in prognostic models.

Original languageEnglish
Pages (from-to)714-716
Number of pages3
JournalBritish Journal of Cancer
Volume125
Issue number5
Early online date14 Jun 2021
DOIs
Publication statusPublished - 31 Aug 2021

Bibliographical note

© 2021. The Author(s).

Fingerprint

Dive into the research topics of 'The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study'. Together they form a unique fingerprint.

Cite this